Lawmakers benefit from taxes generated from biotech, and big pharma companies that are generating massive revenues. Expecting LABU ~$50-55 range by mid September.
Note
This is when the highs are tested. I would expect a flat line until December. The profit margin is more of a gamble than can be rationally predicted.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.